Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

Fig. 2

OS and BCSS (A, B) in HR-positive breast cancer and (C, D) in TNBC. No significant difference was noted in overall survival between patients with HER2-low breast cancer and those with HER2-IHC 0 breast cancer, but breast cancer-specific survival was significantly better in patients with HER2-low breast cancer than in those with HER2-IHC 0 breast cancer

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us